Overlap of systemic sclerosis and rheumatoid arthritis.
Alkassab
Firas
F
Division of Rheumatology and Clinical Immunogenetics, The University of Texas-Houston Health Science Center, Houston, Texas 77030, USA. Firas.Alkassab@uth.tmc.edu
D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000000981:diagnostic imaging / Q000188:drug therapy; D004359:Drug Therapy, Combination; D000068800:Etanercept; D005260:Female; D006225:Hand / Q000000981:diagnostic imaging; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D011859:Radiography; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D012219:Rheumatology / Q000379:methods*; D012595:Scleroderma, Systemic / Q000150:complications* / Q000000981:diagnostic imaging / Q000188:drug therapy; D016896:Treatment Outcome
D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept; D008727:Methotrexate